lung cancer
-
December 8, 2022
Lovly receives Asclepios Award from GO2 for Lung Cancer
Vanderbilt's Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers. -
October 20, 2022
Event set to make lung cancer screening more accessible
Vanderbilt University Medical Center is making the lung cancer screening more convenient with weekend appointments from 8 a.m. to noon on Saturday, Nov. 12, at Vanderbilt Health One Hundred Oaks -
September 29, 2022
Policy, resources crucial for lung cancer screening: study
Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened. -
September 15, 2022
Lung cancer detection program lands grant renewal
The National Cancer Institute has renewed funding for the Early Detection Research Network Lung Cancer Clinical Validation Center at Vanderbilt- Ingram Cancer Center. -
August 2, 2022
Targeted cancer drug during pregnancy
The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians. -
August 1, 2022
H. pylori and lung cancer
Specific biomarkers for H. pylori — a bacterium that infects the stomach — were associated with increased risk of lung cancer, Vanderbilt researchers have discovered. -
July 28, 2022
Study reveals need for matching targeted therapies with EGFR subtypes
A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers.